| Cyclooxygenase-2 is overexpressed in human cervical cancer S Kulkarni, JS Rader, F Zhang, H Liapis, AT Koki, JL Masferrer, ... Clinical Cancer Research 7 (2), 429-434, 2001 | 461 | 2001 |
| A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer CA Haiman, GK Chen, CM Vachon, F Canzian, A Dunning, RC Millikan, ... Nature genetics 43 (12), 1210-1214, 2011 | 354 | 2011 |
| Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India MS Dhar, R Marwal, R Vs, K Ponnusamy, B Jolly, RC Bhoyar, V Sardana, ... Science 374 (6570), 995-999, 2021 | 327 | 2021 |
| Delay to formalin fixation effect on breast biomarkers T Khoury, S Sait, H Hwang, R Chandrasekhar, G Wilding, D Tan, ... Modern Pathology 22 (11), 1457-1467, 2009 | 257 | 2009 |
| HER2+ breast cancer: review of biologic relevance and optimal use of diagnostic tools DG Hicks, S Kulkarni American journal of clinical pathology 129 (2), 263-273, 2008 | 217 | 2008 |
| Common breast cancer susceptibility loci are associated with triple-negative breast cancer KN Stevens, CM Vachon, AM Lee, S Slager, T Lesnick, C Olswold, ... Cancer research 71 (19), 6240-6249, 2011 | 153 | 2011 |
| The breast–thyroid cancer link: a systematic review and meta-analysis SM Nielsen, MG White, S Hong, B Aschebrook-Kilfoy, EL Kaplan, ... Cancer Epidemiology, Biomarkers & Prevention 25 (2), 231-238, 2016 | 149 | 2016 |
| Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study S Yao, LE Sucheston, AE Millen, CS Johnson, DL Trump, MK Nesline, ... PloS one 6 (2), e17251, 2011 | 141 | 2011 |
| Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998–2009 JL Gnerlich, RT Williams, K Yao, N Jaskowiak, SA Kulkarni Annals of surgical oncology 21, 1222-1230, 2014 | 133 | 2014 |
| Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020 N Gupta, I Praharaj, T Bhatnagar, JWV Thangaraj, S Giri, H Chauhan, ... Indian Journal of Medical Research 151 (2-3), 236-240, 2020 | 96 | 2020 |
| Postoperative adjuvant systemic therapy in completely resected non–small-cell lung cancer: a systematic review P Bradbury, D Sivajohanathan, A Chan, S Kulkarni, Y Ung, PM Ellis Clinical lung cancer 18 (3), 259-273. e8, 2017 | 96 | 2017 |
| Role of amino acids as additives on sperm motility, plasma membrane integrity and lipid peroxidation levels at pre-freeze and post-thawed ram semen S Sangeeta, A Arangasamy, S Kulkarni, S Selvaraju Animal reproduction science 161, 82-88, 2015 | 89 | 2015 |
| Society of surgical oncology breast disease working group statement on prophylactic (risk-reducing) mastectomy KK Hunt, DM Euhus, JC Boughey, AB Chagpar, SM Feldman, NM Hansen, ... Annals of surgical oncology 24, 375-397, 2017 | 86 | 2017 |
| Trastuzumab as adjuvant therapy for early breast cancer: the importance of accurate human epidermal growth factor receptor 2 testing DG Hicks, S Kulkarni Archives of pathology & laboratory medicine 132 (6), 1008-1015, 2008 | 82 | 2008 |
| Effect of delayed formalin fixation on estrogen and progesterone receptors in breast cancer: a study of three different clones J Qiu, S Kulkarni, R Chandrasekhar, M Rees, K Hyde, G Wilding, D Tan, ... American journal of clinical pathology 134 (5), 813-819, 2010 | 73 | 2010 |
| Increased expression levels of WAVE3 are associated with the progression and metastasis of triple negative breast cancer S Kulkarni, K Augoff, L Rivera, B McCue, T Khoury, A Groman, L Zhang, ... Public Library of Science 7 (8), e42895, 2012 | 60 | 2012 |
| Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status SE McCann, S Kulkarni, M Trevisan, D Vito, J Nie, SB Edge, P Muti, ... Breast cancer research and treatment 99, 309-311, 2006 | 60 | 2006 |
| Implementation of image processing for detection of brain tumors SS Hunnur, A Raut, S Kulkarni 2017 International Conference on Computing Methodologies and Communication …, 2017 | 59 | 2017 |
| A lysosome-targeted DNA nanodevice selectively targets macrophages to attenuate tumours C Cui, K Chakraborty, XA Tang, KQ Schoenfelt, A Hoffman, A Blank, ... Nature nanotechnology 16 (12), 1394-1402, 2021 | 58 | 2021 |
| COX-2 and PPARγ expression are potential markers of recurrence risk in mammary duct carcinoma in-situ S Kulkarni, DB Patil, LK Diaz, EL Wiley, M Morrow, SA Khan BMC cancer 8, 1-11, 2008 | 56 | 2008 |
